184 related articles for article (PubMed ID: 17053396)
1. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H
Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396
[TBL] [Abstract][Full Text] [Related]
2. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
3. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
4. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of bone marrow
Lee JW; Lee SC; Kim HJ; Lee SM
Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma.
Varoglu E; Kaya B; Sari O
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):43-5. PubMed ID: 23177344
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET.
Seshadri N; Wright P; Balan KK
Clin Nucl Med; 2007 Oct; 32(10):787-9. PubMed ID: 17885359
[TBL] [Abstract][Full Text] [Related]
9. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography.
Takalkar A; Yu JQ; Kumar R; Xiu Y; Alavi A; Zhuang H
Clin Nucl Med; 2004 Oct; 29(10):637-9. PubMed ID: 15365439
[No Abstract] [Full Text] [Related]
10. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging.
Hollinger EF; Alibazoglu H; Ali A; Green A; Lamonica G
Clin Nucl Med; 1998 Feb; 23(2):93-8. PubMed ID: 9481497
[TBL] [Abstract][Full Text] [Related]
12. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT.
Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H
Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173
[TBL] [Abstract][Full Text] [Related]
13. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow.
Kazama T; Swanston N; Podoloff DA; Macapinlac HA
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1406-11. PubMed ID: 16133379
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Adams HJ; Nievelstein RA; Kwee TC
Blood Rev; 2015 Nov; 29(6):417-25. PubMed ID: 26113144
[TBL] [Abstract][Full Text] [Related]
15. Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor.
Ojha B; Muthukrishnan A; Raman AK; Satya R; Mahone T; Forero-Torres A
Clin Nucl Med; 2004 Sep; 29(9):600-1. PubMed ID: 15311141
[No Abstract] [Full Text] [Related]
16. Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography.
Kato T; Tsukamoto E; Nishioka T; Yamazaki A; Shirato H; Kobayashi S; Asaka M; Imamura M; Tamaki N
Clin Nucl Med; 2000 Nov; 25(11):870-3. PubMed ID: 11079582
[TBL] [Abstract][Full Text] [Related]
17. Increased FDG uptake of the bone marrow mimicking malignancy in a patient of eosinophilia secondary to Sparganum mansoni infection.
Dong A; Wang Y; Gao L; Zuo C
Clin Nucl Med; 2014 Jul; 39(7):640-2. PubMed ID: 23877523
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
Castellani M; Carletto M; Baldini L; Calori R; Longari V; Soligo D; Dellavedova L; Gerundini P
Clin Nucl Med; 2010 Jan; 35(1):1-5. PubMed ID: 20026963
[TBL] [Abstract][Full Text] [Related]
19. Diffuse homogeneous bone marrow uptake of FDG in patients with acute lymphoblastic leukemia.
Su K; Nakamoto Y; Nakatani K; Kurihara K; Hayakawa N; Togashi K
Clin Nucl Med; 2013 Jan; 38(1):e33-4. PubMed ID: 23242061
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
